Menu

News

« » View all News

CPTR 2014 Rapid DST Workshop Report Day 2

DAY 2: SEPTEMBER 23, 2014

MODELING TO EVALUATE DEPLOYMENT STRATEGY FOR DRUG SUSCEPTIBILITY TESTING

Objective: Discuss the impact of modeling efforts on diagnostics development and RDST Consortium work streams.

TECHNOLOGICAL PLATFORMS FOR TB DST DIAGNOSTICS

Objective: Discuss the impact of emerging technical platforms and their direct impact and implications for the CPTR RDST Consortium’s goals and work streams.

ROADMAP & ENABLING SCIENCES FOR RDST CONSORTIUM

Objective: Discuss the scientific gaps for developing rapid nucleic acid tests to detect resistance to newer anti-TB drugs.
Moderator: Barry Kreiswirth, Rutgers University

SURVEILLANCE DATA FOR RAPID DST DEVELOPMENT

Objective: Identify the challenges and opportunities for implementing genotypic data for DST surveillance and discuss harmonization requirements.
Moderator: Angela Starks. See Angela Stark’s video.

CLINICAL TRIALS – PROGRESS AND POTENTIAL PARTNERSHIPS

Objective: Discuss the impact of clinical trials on diagnostics development and RDST Consortium work streams.
Moderator: Jamie Posey, CDC. See Jamie Posey’s video.

RAPID DST – WHAT CLINICIANS WOULD CONSIDER SUCCESS

Presenter:
Martina Casenghi, MSF Access Campaign
Martina Cashenghi presented perspectives from MSF clinicians on what would constitute success in rapid DST efforts. The presentation focused primarily on current and short-term needs, and included intended use of the tests, the need for decentralization of DST testing, and the need to work towards both a patient-centered enabling context as well as implementation of enabling technologies on the ground.
See Martina Cashenghi’s video.

Closing Remarks
Marco Schito closed the session.
See Marco Schito’s video.

« » View all News